Healthcare Fraud Analytics Market Report 2026

The healthcare fraud analytics market size has grown exponentially in recent years. It will grow from $4.65 billion in 2025 to $5.93 billion in 2026 at a compound annual growth rate (CAGR) of 27.5%. The growth in the historic period can be attributed to increasing healthcare claim volumes, rising complexity of billing processes, growth in digital healthcare transactions, expansion of insurance coverage programs, availability of healthcare data analytics tools.

The healthcare fraud analytics market size is expected to see exponential growth in the next few years. It will grow to $15.37 billion in 2030 at a compound annual growth rate (CAGR) of 26.9%. The growth in the forecast period can be attributed to increasing investments in advanced fraud prevention platforms, rising regulatory scrutiny on healthcare payments, expansion of machine learning-based analytics, growing adoption of cloud-based fraud solutions, increasing focus on cost containment in healthcare. Major trends in the forecast period include increasing use of predictive fraud detection models, rising adoption of real-time claims analytics, growing integration of ai-driven anomaly detection, expansion of automated payment integrity solutions, enhanced focus on prepayment fraud prevention.

A significant rise in fraudulent activities within the healthcare sector is driving the growth of the healthcare fraud analytics market. Fraud can be perpetrated by medical providers, patients, and third parties who intentionally deceive the healthcare system to gain unlawful benefits through deception or misrepresentation. Common fraudulent practices include kickbacks, improper billing, billing for services not rendered, and other deceptive activities. For instance, in December 2023, the U.S. Department of Health and Human Services (HHS) reported that healthcare fraud investigations resulted in recoveries totaling over $1.72 billion, with about $1.2 billion being returned to the Medicare Trust Funds. Furthermore, the Department of Justice (DOJ) noted that in fiscal year 2023, settlements and judgments under the False Claims Act exceeded $2.68 billion, highlighting a robust enforcement response to fraudulent practices. These statistics underscore the substantial financial impact of healthcare fraud, which is estimated to cost the nation billions annually, with some estimates suggesting losses could reach as high as 10% of annual healthcare expenditures. Thus, the increasing prevalence of fraudulent activities in healthcare is significantly contributing to the growth of the healthcare fraud analytics market.

Key companies in the healthcare fraud analytics market are concentrating on strategic investments to strengthen their market presence. Growing technological advancements in healthcare fraud analytics indicate an increasing allocation of funds toward sophisticated analytical tools and technologies designed to detect and prevent fraudulent activities across the healthcare sector. For example, in August 2024, MediBuddy, an India-based digital healthcare company, introduced an advanced AI-driven fraud detection system called Sherlock to address healthcare fraud, particularly in medical reimbursement claims. This state-of-the-art platform leverages advanced artificial intelligence (AI) and machine learning (ML) technologies to detect and prevent fraudulent activities in real time, thereby improving the overall integrity of the healthcare system.

In August 2024, Experian, an Ireland-based business services firm, acquired NeuroID for an undisclosed amount. This acquisition is intended to bolster Experian's identity verification and fraud prevention capabilities by incorporating NeuroID's behavioral analytics technology. This integration will provide deeper insights into consumer behavior and enhance the detection of fraudulent activities across digital interactions. NeuroID is a US-based software company specializing in healthcare fraud analytics.

Major companies operating in the healthcare fraud analytics market are International Business Machines Corporation; Optum Inc.; Statistical Analysis Software Institute Inc.; Change Healthcare; EXL Service Holdings Inc.; Cotiviti Inc.; DXC Technology Company; Wipro Limited; Conduent Incorporated; HCL Technologies Limited; Qlarant Inc.; LEXIS-NEXIS Group; Healthcare Fraud Shield; FraudLens Inc.; HMS Holding Corp.; Codoxo; H20. ai; Pondera Solutions Inc.; Friss International B. V.; MultiPlan Inc.; FraudScope; Osp Labs Private Limited; Fair Isaac Corporation; Relx Group PLC.

North America was the largest region in the healthcare fraud analytics market in 2025.North America is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare fraud analytics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the healthcare fraud analytics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the healthcare fraud analytics market by increasing costs of imported servers, analytics hardware, data processing infrastructure, and cybersecurity components used in on-premise and hybrid deployments. Healthcare payers and large providers in North America and Europe are most affected due to reliance on imported IT infrastructure, while Asia-Pacific faces higher costs for analytics platform expansion. These tariffs are increasing implementation costs and delaying system upgrades. However, they are also accelerating migration toward cloud-based analytics, local data center usage, and software-centric fraud detection solutions.

The healthcare fraud analytics market research report is one of a series of new reports that provides healthcare fraud analytics market statistics, including healthcare fraud analytics industry global market size, regional shares, competitors with a healthcare fraud analytics market share, detailed healthcare fraud analytics market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare fraud analytics industry. This healthcare fraud analytics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Healthcare fraud analytics refers to on-premise and on-demand analytical solutions that assist in identifying issues such as duplication/repetition of claims and errors in claim healthcare operations and applications. Healthcare fraud analytics aims to help healthcare companies to audit their accounts and find out fraudulent activities in various transactions. It identifies frauds related to billings, claims, prepayment, post payments, and payment integrity.

The main type of solutions in healthcare fraud analytics are descriptive analytics, predictive analytics, prescriptive analytics. Descriptive analytics is a process of using current and historical data to identify trends and relationships. Healthcare fraud analytic solutions are deployed on-premise and on-demand, and they are widely used for insurance claims review, postpayment review, prepayment review, pharmacy billing misuse, payment integrity, other applications. Healthcare fraud analytics are used by public & government agencies, private insurance payers, third-party service providers.

The healthcare fraud analytics market includes revenues earned by entities by providing services such as fraud detection, predictive analytics, and Medicaid. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.